Clinical Trials Logo

Clinical Trial Summary

This study was conducted to assess the combine role of Physiotherapy by providing task specific trainings and Botulinum Toxin Type A in improving the functional outcomes of upper limb in post stroke patients with focal hand dystonia.


Clinical Trial Description

Post-stroke hemiparesis, with dystonia, is a major cause of disability. Dystonia can hinder the functional activities making patient dependent on others for performance of daily living activities. Dystonia not only limits the physical activity of the patient but also affects their quality of life significantly. Various treatment protocols have been used in the literature for treatment of focal hand dystonia in the past including deep brain stimulation, kinesio taping, sensory oriented training, splinting, extracorporeal shock wave therapy and botox. Out of these Botox has gained much importance but it results only in improving the passive range of motion and has no consensus in improving the active range of motion and functional independence of the patient. The current study was planned to determine the effects of botulinum toxin type A combined with task-specific therapy, for post-stroke focal dystonia of upper limb. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03664375
Study type Interventional
Source Isra University
Contact
Status Completed
Phase N/A
Start date November 2015
Completion date December 2016

See also
  Status Clinical Trial Phase
Completed NCT00376753 - Muscle Contraction in Patients With Focal Hand Dystonia N/A
Completed NCT00325091 - Long-Term Motor Learning in Focal Hand Dystonia
Recruiting NCT00579033 - Somatosensory Processing in Focal Hand Dystonia N/A
Completed NCT00106782 - Transcranial Electrical Polarization to Treat Focal Hand Dystonia Phase 2
Recruiting NCT03977493 - IncobotulinumtoxinA (Xeomin) to Treat Focal Hand Dystonia Phase 3